Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: A lesson from the past

Table 5 2-yr survival and rebleeding rate in randomized controlled trials comparing DSRS with ES

	Warren[5]	Terés[7]	Rikkers[6]	Our data
2-yr survival rate
after DSRS	59%a	71%	65%	95%
2-yr survival rate
after ES	84%a	68%	61%	85%
Child's C patients	43%	0	33%	0
Interval between bleeding
and treatment (d)	> 3-5	10-15	NR	901
Rebleeding rate after
DSRS	3%a	14%a	19%a	2.5%a
Rebleeding rate after
ES	53%a	37%a	57%a	35%a
Variceal eradication
rate	NR	46%	63%	90%
Failure to salvage
rebleeders	17%	33%	47%	14%
Shunt for ES failure	31%	6%	7%	5%
Global mortality rate
due to rebleeding	3%	14%	27%	16%
Global mortality rate
due to other causes	13%	16%	13%	17%

NR = Not reported; ¹mean value;

^aP < 0.05 vs ES.